Genomics-Informed Drug Repurposing Strategy Identifies Novel Therapeutic Targets for Metabolic Dysfunction-Associated Steatotic Liver Disease.
Seagle, H. M.; Akerele, A. P.; DeCorte, J. A.; Hellwege, J. N.; Breeyear, J. H.; Kim, J.; Levin, M.; Khodurksy, S.; Bress, A. P.; Lee, K.; Meiler, J.; Gill, D.; Lee, J. S.; Heberer, K.; Miller, D. R.; Reavan, P.; Chang, K.-M.; Lynch, J.; Khankari, N. K.; Shuey, M.; Edwards, T. L.; Vujkovic, M.
Show abstract
Identification of drug-repurposing targets with genetic and biological support is an economically and temporally efficient strategy for improving treatment of diseases. We employed a cross-disciplinary approach to identify potential treatments for metabolic dysfunction associated steatotic liver disease (MASLD) using humans as a model organism. We identified 212 putative causal genes associated with MASLD using data from a large multi-ancestry genetic association study, of which 158 (74.5%) are novel. From this set we identified 57 genes that encode for druggable protein targets, and where the effects of increasing genetically predicted gene expression on MASLD risk align with the function of that drug on the protein target. These potential targets were then evaluated for evidence of efficacy using Mendelian randomization, pathway analysis, and protein structural modeling. Using these approaches, we present compelling evidence to suggest activation of FADS1 by icosopent ethyl as well as S1PR2 by fingolimod could be promising therapeutic strategies for MASLD.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Enhanced muscle uptake of chemically optimized miR-23b antisense oligonucleotides as lead compounds for Myotonic Dystrophy type 1 93%
- Development of a novel oral treatment that rescues gait ataxia and retinal degeneration in a phenotypic mouse model of familial dysautonomia. 93%
- Dystonia-specific mutations in THAP1 alter transcription of genes associated with neurodevelopment and myelin 92%
Similar papers in this journal
- Genome-wide association study reveals shared and distinct genetic architecture underlying fatty acid and bioactive oxylipin metabolites in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) 92%
- Personalized structural biology reveals the molecular mechanisms underlying heterogeneous epileptic phenotypes caused by de novo KCNC2 variants 91%
- Pathway-specific polygenic scores substantially increase the discovery of gene-adiposity interactions impacting liver biomarkers 91%
Similar papers in this journal
Similar papers in this journal
- Identification of a cardiac glycoside exhibiting favorable brain bioavailability and potency for reducing levels of the cellular prion protein 92%
- Connectivity analysis of single cell RNA-sequencing derived transcriptional signature of lymphangioleiomyomatosis 92%
- Towards new AQP4 inhibitors: ORI-TRN-002 92%
Similar papers in this journal
- From atoms to cells: bridging the gap between potency, efficacy, and safety of small molecules directed at a membrane protein 94%
- Network and pathway expansion of genetic disease associations identifies successful drug targets 92%
- A screen of FDA-approved drugs identifies inhibitors of Protein Tyrosine Phosphatase 4A3 (PTP4A3 or PRL-3) 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.